In the post-progression HCC tissue compared with the baseline tissue, the expression of PD-L1 in tumor-infiltrating immune cells and the abundance of CD8<sup>+</sup> T cells in the tumor area had decreased, and an immune-excluded TME had emerged. The gene discussed is CD8A; the disease is hepatocellular carcinoma.